Development of immunotherapy targeting pathological TDP-43 in ALS and ftld
Ended Project Grant Awarded Last action
- Award ID
- R21NS117982
- Recipient
-
University Of Zurich UEI H3J4PPC8LZV6
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $438,509
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Funding
-
- $337,408.00 Federal
- $101,101.00 Non-federal
- Place of performance
- Switzerland
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $101,101 | $0 | |
| Amendment | $101,101 | $101,101 | |
| Original award | $135,206 | $0 |
Quick answers
Who received award R21NS117982?
R21NS117982 was awarded to University Of Zurich by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on June 15, 2020.
How much is award R21NS117982 worth?
$438,509 has been obligated on R21NS117982: $337,408 in federal funding and $101,101 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award